Table 1.

Characterization of iPSCs

	Name	Race	Gender	Age	CAG repeat	iPSC clones
SBMA	SBMA1	Japanese	male	42	52	SBMA1E-12, 18
	SBMA2	Japanese	male	46	47	SBMA2E-16, 44
	SBMA3	Japanese	male	33	50	SBMA3E-10, 11
	SBMA4	Japanese	male	38	49	SBMA4E-5, 21
Control	TIG114	Japanese	male	36	24	TIGE-9a, 22
	YF	Japanese	male	24	21	YFE-16a, 19
	KN	Japanese	male	39	20	EKN3b

All SBMA patients were not treated with leuprorelin at the time of skin biopsy

^a [20], ^b [21]